Insulin Therapy with Personal Insulin Pumps and Early Angiopathy in Children with Type 1 Diabetes Mellitus by Joanna Tołwińska, Barbara Głowińska-Olszewska, Artur Bossowski

Get full text

The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps by Tomasz Klupa, Teresa Benbenek-Klupa, Bartlomiej Matejko, Sandra Mrozinska, Maciej T. Malecki

“…We aimed to estimate the impact of ingestion of a pure protein load on the glucose levels in T1DM patients treated with insulin pumps. We examined 10 T1DM patients (6 females, mean age—32.3 years, mean HbA1c—6.8%) treated with insulin pumps equipped with a continuous glucose monitoring system (CGMS). …”
Get full text

Performance of a Continuous Subcutaneous Insulin Infusion (CSII) Pump With Acoustic Volume and Flow Sensing in Simulated High-Consequence Situations by Robert D. Butterfield, Nathaniel M. Sims

Subjects: Get full text

Trends in Glycemia between 2002 and 2016 among Incident Youth Cohorts Early in the Course of Type 1 Diabetes: The SEARCH for Diabetes in Youth Study by Daria Igudesman, Beth A. Reboussin, Katherine J. Souris, Catherine Pihoker, Lawrence Dolan, Jean M. Lawrence, Sharon Saydah, Dana Dabelea, Santica Marcovina, Noémie Clouet-Foraison, Faisal S. Malik, Elizabeth J. Mayer-Davis

“…We tested the hypothesis that there were temporal trends in population-level glycemia and insulin pump use near T1D diagnosis among incident youth cohorts diagnosed between 2002 and 2016. …”
Get full text

Effect of Optimization of Glycaemic Control on Mannan-Binding Lectin in Type 1 Diabetes by Gry Høst Dørflinger, Charlotte Brink Holt, Steffen Thiel, Jakob Appel Østergaard, Troels Krarup Hansen

“…We measured MBL, fructosamine, and HbA1cat baseline and after 6 weeks in 52 type 1 diabetic patients following the change from conventional insulin therapy to insulin pump therapy. Results. After initiation of insulin pump therapy, the total daily insulin dose was significantly reduced (from 51 ± 18 IE/day to 39 ± 13 IE/day, P<0.0001). …”
Get full text

Acute Hyperglycemia Due to Topical Corticosteroid Administration by Laura Y. Sue, Anna Milanesi

“…His insulin requirements, via his insulin pump, increased to nearly five times his typical daily dose. …”
Get full text

Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring by Ming Yeh Lee, Anna L. Gloyn, David M. Maahs, Priya Prahalad

“…We describe the use of continuous glucose monitoring (CGM), insulin pump, automated insulin delivery system, and remote patient monitoring technologies to facilitate rapid and safe outpatient cross-titration from insulin to oral sulfonylurea. …”
Get full text

Acute Psychosis in Withdrawal from Nicotine Vaping in a Young Man with Comorbid Diabetic Ketoacidosis and Cannabis Use by Kyle J. Rutledge, Dianne L. Plath

“…The current report presents the case of a young man with multiple medical comorbidities, including insulin-dependent diabetes mellitus on an insulin pump and presumed Gilbert’s disease, and chronic cannabis use who experienced acute agitation with hallucinations in the context of quitting his vape pen “cold turkey” or abruptly discontinuing use without a nicotine replacement. …”
Get full text

A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices by Daisuke Takahashi, Yang Xiao, Fei Hu, Michael Lewis

“…These medical devices include automated insulin pumps and blood glucose sensors. Insulin pumps are designed to create artificial insulin perfusion while they largely rely on the blood glucose profile measurements and these measurements are achieved by one or more blood glucose sensors. …”
Get full text

Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes by Ewa M. Sokolewicz, Kamil Dzwilewski, Natalia Omieczyńska, Marta Zawadzka, Maria Mazurkiewicz-Bełdzińska

“…Here, we report a case of an 11-year old male patient diagnosed with type 1 diabetes mellitus treated with the use of insulin pump who was admitted to the Pediatric Neurology Department because of multiple incidents of seizures. …”
Get full text

Effects of switching from MiniMed™ 640G to 770G on continuous glucose monitoring metrics and DTR‐QOL scores: An observational study of Japanese people with type 1 diabetes mellitus... by Toshiki Kogai, Junko Sato, Haruna Yasuda, Tatsuhiro Ayame, Azusa Ozaki, Eri Takagi, Mami Koshibu, Yuya Nishida, Fuki Ikeda, Hirotaka Watada

“…ABSTRACT Aims/Introduction We evaluated the effect of the MiniMed™ 770G, an insulin pump using hybrid closed‐loop technology, on blood glucose management and quality of life in Japanese people with type 1 diabetes. …”
Get full text

Enhanced Cognitive Walkthrough: Development of the Cognitive Walkthrough Method to Better Predict, Identify, and Present Usability Problems by Lars-Ola Bligård, Anna-Lisa Osvalder

“…The ECW method has been employed to evaluate user interface designs of medical equipment such as home-care ventilators, infusion pumps, dialysis machines, and insulin pumps. The method has proved capable of identifying several potential use problems in designs.…”
Get full text

Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes by Boris P. Kovatchev

“…Technology integrating CGM with insulin pumps is now available, opening the field for automated closed-loop control, known as the artificial pancreas. …”
Get full text

Use and Trends of Diabetes Self-Management Technologies: A Correlation-Based Study by Jesús Fontecha, Iván González, Alfonso Barragán, Theodore Lim

“…In this study, more than 70% of participants use Continuous Glucose Systems and additional devices (41.85% also use insulin pumps) which impacts positively on the knowledge of incoming technologies. …”
Get full text

Stable Metabolic Control but Increased Demand for Professional Support in Children with Type 1 Diabetes in the Past Ten Years in Bern/Switzerland: A Quality Control Study by Michelle J. Dennig, Grit Sommer, Tanja Zingg, Christa E. Flück, Claudia Boettcher

“…Compared to historical data, stable HbA1c levels appeared with a doubled proportion of individuals using insulin pumps. Metabolic control was worse with a longer duration of diabetes and younger age at diagnosis but better when parents came from a Western European country. …”
Get full text

Position statement of the Polish Society of Allergology and Polish Dermatological Society regarding the limited accessibility of materials necessary for patch testing. Part I: Tech... by Roman Nowicki, Magdalena Czarnecka-Operacz, Elżbieta Grubska-Suchanek, Marta Kieć-Świerczyńska, Cezary Kowalewski, Beata Kręcisz, Jerzy Kruszewski, Maciej Kupczyk, Cezary Pałczyński, Jacek Szepietowski, Magdalena Trzeciak, Jolanta Walusiak-Skorupa, Radosław Śpiewak

“…Cases of allergic reactions to implanted medical devices are also on the rise, causing failures of endoprostheses, implants, insulin pumps, pacemakers and vascular stents. At present, the only validated method and a gold standard of detecting type IV allergy are patch tests. …”
Get full text

Physiological Characteristics of Type 1 Diabetes Patients during High Mountain Trekking by Bartłomiej Matejko, Andrzej Gawrecki, Marta Wróbel, Jerzy Hohendorff, Teresa Benbenek-Klupa, Dorota Zozulińska-Ziółkiewicz, Maciej T. Malecki, Tomasz Klupa

“…After a 3-day expedition, 18 T1DM patients, all treated with personal insulin pumps, successfully climbed Mount Damavand. Information was collected on their physiological and dietary behaviors, as well as medical parameters, such as carbohydrate consumption, glucose patterns, insulin dosing, and the number of hypo- and hyperglycemic episodes during this time frame. …”
Get full text

Fasting Plasma Glucose Indicates Reversibility of the Acute Insulin Response after Short-Term Intensive Insulin Therapy in Patients with Various Duration of Type 2 Diabetes by Liehua Liu, Siyue Yang, Jianbin Liu, Hai Li, Juan Liu, Xiaopei Cao, Haipeng Xiao, Yanbing Li

“…Participants were treated with SIIT using insulin pumps to achieve near normoglycemia for 7 days. …”
Get full text

Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study by Paola Pantanetti, Giovanni Cangelosi, Sara Morales Palomares, Gaetano Ferrara, Federico Biondini, Stefano Mancin, Gabriele Caggianelli, Mauro Parozzi, Marco Sguanci, Fabio Petrelli

“…Advances in diabetes management, such as continuous glucose monitoring (CGM), insulin pumps (IP), and, more recently, smart multiple dose injection (MDI) pens, have significantly enhanced glycemic control and improved patients’ quality of life. …”
Get full text